SCHEMBL30607362

SCHEMBL30607362

CC[C@H](C)[C@H](NC(=O)[C@@H](N)CO)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](C)O)C(C)C

nearest known ligand 0.67

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ PTH1R Q03431 7/20 0.67
▸ RXFP1 Q9HBX9 6/20 0.67
▸ GLP1R P43220 6/20 0.64
▸ CCKBR P32239 1/20 0.64
▸ KEAP1 Q14145 1/20 0.61
▸ GCGR P47871 1/20 0.60
▸ GIPR P48546 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31182833 0.92 PTH1R (0.70) PTH1RRXFP1GLP1RCCKBRGCGR
SCHEMBL30279832 0.92 RXFP1 (0.70) PTH1RRXFP1GLP1RCCKBR
SCHEMBL29679523 0.92 GLP1R (0.69) PTH1RRXFP1GLP1RCCKBR
SCHEMBL30658341 0.90 GLP1R (0.69) PTH1RRXFP1GLP1RCCKBRKEAP1
SCHEMBL30262138 0.90 TLR2 (0.61) PTH1RRXFP1GLP1RCCKBRKEAP1
SCHEMBL31182558 0.89 RXFP1 (0.72) PTH1RRXFP1GLP1RCCKBRKEAP1
SCHEMBL29679760 0.89 GLP1R (0.65) RXFP1GLP1RCCKBR
SCHEMBL30658300 0.89 PTH1R (0.72) PTH1RRXFP1GLP1RCCKBRKEAP1
SCHEMBL31020886 0.88 RXFP1 (0.66) PTH1RRXFP1GLP1RCCKBRGCGR
SCHEMBL28081239 0.88 GLP1R (0.64) RXFP1GLP1RGCGRGIPR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12383505-B2 Nanoparticle for the remodeling of cancer-associated fibroblasts UNIVERSITY OF SOUTH CAROLINA (US) 2025-08-12 — — US disclosed
US-20230310331-A1 NANOPARTICLE FOR THE REMODELING OF CANCER-ASSOCIATED FIBROBLASTS UNIVERSITY OF SOUTH CAROLINA (US) 2023-10-05 — — US disclosed
Send feedback